Cargando…
Seroprevalence and attainment of herd immunity against SARS CoV-2: A modelling study
OBJECTIVE: The present study aims to predict the likelihood of and likely time required to attain herd immunity against COVID-19 in New Delhi due to natural infection. METHOD: An ODE-based mathematical model was constructed by extending the classical SEIR model to predict the seroprevalence rate. We...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797069/ https://www.ncbi.nlm.nih.gov/pubmed/35136763 http://dx.doi.org/10.4103/jfmpc.jfmpc_830_21 |
_version_ | 1784641461020524544 |
---|---|
author | Paul, Abhijit Kadnur, Harshith B. Ray, Animesh Chatterjee, Samrat Wig, Naveet |
author_facet | Paul, Abhijit Kadnur, Harshith B. Ray, Animesh Chatterjee, Samrat Wig, Naveet |
author_sort | Paul, Abhijit |
collection | PubMed |
description | OBJECTIVE: The present study aims to predict the likelihood of and likely time required to attain herd immunity against COVID-19 in New Delhi due to natural infection. METHOD: An ODE-based mathematical model was constructed by extending the classical SEIR model to predict the seroprevalence rate. We estimated the parameter values for Delhi using available data (reported cases and the seroprevalence rate) and used them for future prediction. Also, changes in the seroprevalence rate with different possibilities of reinfection were predicted. RESULTS: Maximum seroprevalence rate obtained through our model is 31.65% and also a reduction in the seroprevalence rate was observed for the upcoming one month (month of January, 2021) due to the reduced transmission rate. After increasing the transmission rate to the value same as the third wave in New Delhi, we obtained a maximum value of 54.96%. This maximum value significantly decreased with the reduction in the reinfection possibilities. Also, a little impact of the duration of persistence of antibodies, 180 vs 105 days, was observed on the maximum seroprevalence. CONCLUSION: This modelling study suggests that natural infection alone, as gauged by serial sero-surveys, may not result in attainment of herd immunity in the state of Delhi. |
format | Online Article Text |
id | pubmed-8797069 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-87970692022-02-07 Seroprevalence and attainment of herd immunity against SARS CoV-2: A modelling study Paul, Abhijit Kadnur, Harshith B. Ray, Animesh Chatterjee, Samrat Wig, Naveet J Family Med Prim Care Original Article OBJECTIVE: The present study aims to predict the likelihood of and likely time required to attain herd immunity against COVID-19 in New Delhi due to natural infection. METHOD: An ODE-based mathematical model was constructed by extending the classical SEIR model to predict the seroprevalence rate. We estimated the parameter values for Delhi using available data (reported cases and the seroprevalence rate) and used them for future prediction. Also, changes in the seroprevalence rate with different possibilities of reinfection were predicted. RESULTS: Maximum seroprevalence rate obtained through our model is 31.65% and also a reduction in the seroprevalence rate was observed for the upcoming one month (month of January, 2021) due to the reduced transmission rate. After increasing the transmission rate to the value same as the third wave in New Delhi, we obtained a maximum value of 54.96%. This maximum value significantly decreased with the reduction in the reinfection possibilities. Also, a little impact of the duration of persistence of antibodies, 180 vs 105 days, was observed on the maximum seroprevalence. CONCLUSION: This modelling study suggests that natural infection alone, as gauged by serial sero-surveys, may not result in attainment of herd immunity in the state of Delhi. Wolters Kluwer - Medknow 2021-11 2021-11-29 /pmc/articles/PMC8797069/ /pubmed/35136763 http://dx.doi.org/10.4103/jfmpc.jfmpc_830_21 Text en Copyright: © 2021 Journal of Family Medicine and Primary Care https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Paul, Abhijit Kadnur, Harshith B. Ray, Animesh Chatterjee, Samrat Wig, Naveet Seroprevalence and attainment of herd immunity against SARS CoV-2: A modelling study |
title | Seroprevalence and attainment of herd immunity against SARS CoV-2: A modelling study |
title_full | Seroprevalence and attainment of herd immunity against SARS CoV-2: A modelling study |
title_fullStr | Seroprevalence and attainment of herd immunity against SARS CoV-2: A modelling study |
title_full_unstemmed | Seroprevalence and attainment of herd immunity against SARS CoV-2: A modelling study |
title_short | Seroprevalence and attainment of herd immunity against SARS CoV-2: A modelling study |
title_sort | seroprevalence and attainment of herd immunity against sars cov-2: a modelling study |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797069/ https://www.ncbi.nlm.nih.gov/pubmed/35136763 http://dx.doi.org/10.4103/jfmpc.jfmpc_830_21 |
work_keys_str_mv | AT paulabhijit seroprevalenceandattainmentofherdimmunityagainstsarscov2amodellingstudy AT kadnurharshithb seroprevalenceandattainmentofherdimmunityagainstsarscov2amodellingstudy AT rayanimesh seroprevalenceandattainmentofherdimmunityagainstsarscov2amodellingstudy AT chatterjeesamrat seroprevalenceandattainmentofherdimmunityagainstsarscov2amodellingstudy AT wignaveet seroprevalenceandattainmentofherdimmunityagainstsarscov2amodellingstudy |